Login to Your Account



Valeant Retigabine Phase III Trial Positive for Refractory Epilepsy

By Catherine Hollingsworth


Wednesday, February 13, 2008
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription